A large study conducted in Denmark has found no evidence that popular anti-nausea drug Zofran will harm babies if taken during pregnancy.
Around 10 percent of expectant mothers suffer from morning sickness, including nausea and vomiting, which requires prescription medicine.
Drugs in Pregnancy and Lactation
During pregnancy & lactation a nutritious diet, suitable exercise, adequate rest and a tranquil mind help both the mother and fetus and drugs should be avoided.
Advertisement
Zofran is a popular anti-nausea drug that is often recommended for such women though a study recent suggested that it increased the risk of babies being born with cleft palate if taken by pregnant women.
However a Danish Medical Research Council funded study looked at more than 600,000 did not find any evidence that the drug increases the risk of a major birth defect. Around 1,970 women of the 608,385 pregnancies analyzed by the study took Zofran. The study has been published in the New England Journal of Medicine.
Source: Medindia
Source: Medindia
Diet for Anemia in Pregnancy
A modified diet rich in Folate, Vitamin B12 and Iron is essential for the rapid rise in hemoglobin level.
Advertisement
 Iron & Folate Deficiency Anemia In PregnancyAbout 95% of the anemia cases are due to iron deficiency. | Advertisement
|
Anemia in Pregnancy
Anemia is the commonest blood disorder that may occur in pregnancy and is usually due to low iron or folate reserves of the body and this is reflected as anemia.
Advertisement
Recommended Reading
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial